Many doctors recommend IBS patients on GLP-1 consider a gentle version of the low-FODMAP diet during the early phase of treatment
Its authorisation for weight management will be welcome news for many who have struggled to lose weight in the past and those who have weight-related health problems
Any dose adjustments should be made under prescriber guidance based on overall tolerability and glycaemic control, not specifically for urinary symptoms
Based on these data, the IGF-1 drug itself does not cause oncology, but only has a contraindication to use if you already have cancer or its predisposition (high cancer markers)
Paying off a 24-month CareCredit balance should ideally coincide with the point where you expect to reduce or stop treatment, eliminating the risk of financing medication you no longer need
Kambe, T., Tsuji, T., Hashimoto, A